WALTHAM, Mass. (AP) _ Syndax Pharmaceuticals Inc. (SNDX) on Tuesday reported a loss of $27.7 million in its first quarter.
The Waltham, Massachusetts-based company said it had a loss of 54 cents per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.
The biopharmaceutical company posted revenue of $379,000 in the period.
Syndax shares have declined 28% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $16.04, a fall of 13% in the last 12 months.
The Associated Press